Cardiac abnormalities in patients with refractory epilepsy: Possible relevance for sudden unexpected death

Acta Neurologica Scandinavica, Supplement

Volumn 105, Issue 177, 2002, Pages

  Tigaran, Simona ^a  

^a NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TECHNETIUM 99M; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ANGIOCARDIOGRAPHY; BLOOD PRESSURE MONITORING; CAUSE OF DEATH; DISEASE CLASSIFICATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; EPILEPSY; EPILEPTIC FOCUS; EXERCISE TEST; HEART DISEASE; HEART PROARRHYTHMIA; HEART SCINTISCANNING; HIGH RISK PATIENT; HISTORY OF MEDICINE; HOLTER MONITORING; HUMAN; INCIDENCE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; REVIEW; SEIZURE; ST SEGMENT; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 0036293533     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. What is epilepsy?
2. The epilepsies
3. Elektrisk stormvejr i hjernen
4. The sacred disease
5. On epilepsy and epileptiform convulsions
6. Epilepsies: Definition and background
7. ILAE commission report: A proposed diagnostic scheme for people with epileptic seizures and with epilepsy. Report of the ILAE Task Force on classification and terminology
8. The epidemiology and treatment of chronic and refractory epilepsy
9. The epidemiology of epilepsy
10. Mortality in epilepsy
11. Mortality in epilepsy. A review
12. Mortalité et causes de décès des épileptiques
13. The suiccide rate of epilepsy
14. Increased driving accident frequency in Danish patients with epilepsy
15. Morality
16. Drowning deaths in people with epilepsy
17. Mortality in patients with epilepsy: A study of patients in long-term residential care
18. Hcart disease mortality and morbidity in patients with epilepsy
19. Death in epilepsy
20. Epilepsy and sudden death
21. Sudden unexpected death in epilepsy: Terminology and definitions
22. Sudden unexpected death in epilepsy
23. Population-based study of the incidence of sudden unexplained death in epilepsy
24. Sudden unexpected death in epilepsy: A series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death
25. Temporal lobectomy for refractory epilepsy
26. The mortality associated with epilepsy, with particular reference to sudden unexpected death: A review
27. Incidence and risk factors in sudden unexpected death in epilepsy - A prospective cohort study
28. The effect of treatment on mortality in epilepsy
29. Unexpected death in young epileptics
30. Risk factors for sudden unexpected death in epilepsy: A case control study
31. Electrocardiographic changes during electrographic seizures
32. EKG abnormalities during partial seizures in refractory epilepsy
33. Heart rate and EKG changes in 102 seizures: Role of seizure type, seizure duration, age, AED regime. Location of onset, and preictal state of consciousness
34. ECG changes in epilepsy patients
35. Paroxysmal autonomic dysfunction, epileptogenic activity and sudden death
36. Patients with epilepsy who die suddenly have cardiac disease
37. Post-mortem findings of cardiac lesions in epileptics: A preliminary report
38. Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal averaged ECGs
39. Apnea and bradycardia during epileptic seizures: Relation to sudden death in epilepsy
40. Postictal central apnea as a cause of SUDEP: Evidence from a near-SUDEP incident
41. The role of hypoventilation in a sheep model of epileptic sudden death
42. The ictal bradycardia syndrome
43. Arrhythmia. Heart rate variability and antiepileptic drugs
44. The relationship between ST-segment deviation projected to the front of the chest during exercise and simultaneous Holter monitoring
45. Standards for analysis of ventricular late potentials using high-resolutions or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology
46. The signal-averaged ECG becomes late potential-positive at low noise levels in healthy subjects
47. Longitudinal data analysis using generalized linear models
48. Sudden unexpected death in epilepsy - Regional myocardial blood flow during seizure
49. Comparative evaluation of exercise ST response in healthy males and females. A computer study
50. Abnormal coronary vasomotion in ischemic heart disease
51. Endocardial and epicardial interstitial purines and lactate during graded ischemia
52. Angina due to microvascular pathology
53. Pathophysiology of subendocardial ischemia
54. The myocardial supply: Demand ratio - A critical review
55. Effects of tachycardia on the adequacy of subendocardial oxygen delivery in experimental aortic stenosis
56. Left ventricular function during sudden strenuous exercise
57. Effect of warm-up on left ventricular function
58. Cardiovascular response to sudden strenuous exercise
59. Reflex alpha-adrenergic coronary vasoconstriction during hindlimb static exercise in dogs
60. Carotid sinus baroreceptor control of right coronary circulation in normal, hypertrophied, and failing right ventricles of conscious dogs
61. The relation of cardiac effort to myocardial oxygen consumption and coronary flow
62. Effect of exercise on cardiac output, left coronary flow and myocardial metabolism in the unanesthetized dog
63. Role of autonomic nervous system in the pathogenesis of angina pectoris
64. Neural mechanisms in cardiac arrhythmias associated with epileptogenic activity: The effect of Phenobarbital in the cat
65. Cardiac sympathetic afferent activation provoked by myocardial ischemia and reperfusion
66. Detection of early necrosis in a canine model of low flow myocardial ischemia using 1251-anti-myosin
67. Sudden cardiac death with apparently normal heart
68. Re-entrant mechanisms in ventricular arrhythmias
69. Impact of exercise-induced coronary vasomotion on anti-ischemic therapy
70. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Pathophysiological implications
71. Cardiovascular effects of human insular cortex stimulation
72. The cardiac chronotropic organization of the rat insular cortex
73. Cardiac and respiratory correlations with unit discharge in human amygdala and hippocampus
74. Ictal tachycardia during temporal lobe seizures
75. Autonomic epilepsy - The influence of epileptic discharge on heart and rhythm
76. Autonomic epilepsy
77. Electrocardiographic accompaniments of temporal lobe epileptic seizures
78. Combined depth and subdural electrode investigation in uncontrolled epilepsy
79. True sensitivity of cardiac exercise testing. A combined clinical evaluation of multiple parameters
80. Nonischemic changes of the ST-segment in dynamic electrocardiography
81. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: The case of stress echocardiography
82. Heart rate recovery immediately after exercise as a predictor of mortality
83. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure
84. Autonomic nervous system and sudden cardiac death: Experimental basis and clinical observations for post myocardial infarction risk stratification
85. Changes in plasma catecholamines after epileptic seizures - Possible explanation of SUDEP
86. Standard ECG QRS duration, coronary collaterals, and Q-wave infarction predict late potentials in coronary artery disease
87. Signal-averaged electrocardiography: History, techniques, and clinical applications
88. Interaction or baseline characteristics with the hazard of encainide, flecainide and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the cardiac arrhythmia suppression trail (CAST)
89. Selective prolongation of QRS late potentials by sodium channel blocking antiarrhythmic drugs: Relation to slowing of ventricular tachycardia
90. Oral amiodarone loading therapy. I. The effect on serial signal-averaged eælectrocardiographic recordings and the QTc in patients with ventricular tachyarrhythmias
91. Unexpected, unexplained death in epileptic patients
92. Sudden death in epilepsy
93. Sudden unexpected death associated with seizures, analysis of 66 cases
94. Experience-based teaching of therapeutics and clinical pharmacology of antiepileptic drugs. Sudden unexplained death in epilepsy: Do anti-epileptic drugs have a role?
95. Postmortem changes in blood concentrations of phenytoin and carbamazepine: An experimental study
96. The distribution of plasma phenytoin levels in epileptic patients
97. Unexpected, unexplained death of epileptic persons: Clinical correlation including pulmonary changes
98. Antiepileptic drug therapy in sudden unexpected death in epilepsy a case control study
99. Diphenylhydantoin as an antiarrhythmic drug
100. Cardiac side-effects of phenytoin and carbamazepine. A dose related phenomenon?
101. Complete atrioventricular block with ventricular asystole following infusion of intravenous phenytoin
102. Neural mechanism in cardiac arrhythmias associated with epileptogenic activity: The effect of Phenobarbital in the cat
103. Carbamazepine and heart conduction disorders
104. Total atrioventricular block with syncopes complicating carbamazepine therapy
105. Sinus bradycardia and sinoauricular block induced by carbamazepine
106. Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes
107. Heart rate variability and antiepileptic drugs
108. The 24- hour heart variability. An important predictor of sudden death after myocardial infarction
109. Mortality in antiepileptic drug development programs
110. Critical analysis of the signal-averaged electrocardiogram. Improved identification of late potentials
111. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction?
112. Arrhythmogenic seizures
113. The brainstem cardioarrhythmogenic triggers and their possible role in sudden epileptic death
114. Epilepsy, vagal nerve stimulation by the NCP system, all-cause mortality, and sudden, unexpected, unexplained death
115. Heart rate variability changes as predictor of response to vagal nerve stimulation therapy for epilepsy